Lion Point Capital »

Rocket Pharmaceuticals shares owned by Lion Point Capital

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $280k 86k 3.26

More positions owned by Lion Point Capital

Mineralys Therapeutics (MLYS)
Milestone Pharmaceuticals (MIST)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Ardelyx (ARDX)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Royalty Pharma Shs Class A (RPRX)
Disc Medicine (IRON)
Bridgebio Pharma (BBIO)
Geron Corporation (GERN)
Arcutis Biotherapeutics (ARQT)

View all positions for Lion Point Capital

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Maverick Capital
BlackRock
Vanguard Group
MPM Oncology Impact Management
Suvretta Capital Management
Millennium Management
Morgan Stanley
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Two Sigma Advisers

View all funds holding Rocket Pharmaceuticals